The same can be seen for the reports examining the NF-κB positivity rate (a wide range from 18% to 78.3% [67]) and the relationship of the NF-κB expression status with clinicopathological features of GC patients—from the studies showing a significant relation with some of the traditional clinicopathological parameters, like age, gender, T stage, tumor size, tumor location, histologic grade, Lauren classification, and nodal status [68–70], to those demonstrating no association with any of these features [65]. This evidence concerns the gene NFKB1 and neoplasm.